LCN2 and early-onset autosomal dominant Alzheimer disease: Recent studies have investigated the effects of Lcn2 on Alzheimer’s disease [34, 35], spinal cord injury [36], perioperative neurocognitive disorders [37], and diabetic retinopathy [38].